VA Maryland Health Care System, Baltimore, MD, United States of America; Department of Anesthesiology, University of Maryland, Baltimore, MD, United States of America; VA Central California Health Care System, Fresno, CA, United States of America.
School of Medicine, University of Maryland, Baltimore, MD, United States of America.
J Clin Anesth. 2021 Feb;68:110079. doi: 10.1016/j.jclinane.2020.110079. Epub 2020 Sep 30.
To calculate the incidence and identify the predictors of persistent postoperative opioid use at different postoperative days.
A subset of surgical patients continues to use long-term opioids. The importance of the risk factors at different postoperative days is not known.
A historical cohort.
Postoperative period.
Opioid-naive U.S. veterans.
The surgical group had any one of 19 common invasive procedures. The control group is a 10% random sample. Each control was randomly assigned a surgery date.
The outcomes were the presence of persistent opioid use as determined by continued filling of prescriptions for opioids on postoperative days 90, 180, 270, and 365.
A total of 183,430 distinct surgical cases and 1,318,894 controls were identified. 1.0% of the surgical patients were using opioids at 90 days, 0.6% at 180 days, 0.4% at 270 days, and 0.1% at 365 days after the surgery. Surgery was strongly associated with postoperative persistent opioid use at day 90 (OR 3.67, 95% CI, 3.43-3.94, p < 0.001), at day 180 (OR 2.85, 2.67-3.12, p < 0.001), at day 270 (OR 2.63, 2.38-2.91, p < 0.001) and at day 365 (OR 2.11, 1.77-2.51, p < 0.001) compared to non-surgical controls. In risk factor analysis, being male and single were associated with persistent opioid use at earlier time points (90 and 180 days), while hepatitis C and preoperative benzodiazepine use were associated with persistent opioid use at later time points (270 and 365 days).
Many surgeries or invasive procedures are associated with an increased risk of persistent postoperative opioid use. The postoperative period is dynamic and the risk factors change with time.
计算不同术后天数持续使用阿片类药物的发生率,并确定其预测因素。
一部分手术患者会持续长期使用阿片类药物。不同术后天数的危险因素的重要性尚不清楚。
历史性队列研究。
术后期间。
阿片类药物初治的美国退伍军人。
手术组接受了 19 种常见的有创性操作中的任意一种。对照组是 10%的随机抽样。每个对照组都被随机分配了一个手术日期。
结果是通过术后第 90、180、270 和 365 天继续开阿片类药物处方来确定的持续使用阿片类药物的存在。
共确定了 183430 例不同的手术病例和 1318894 例对照。手术后 90 天有 1.0%的手术患者使用阿片类药物,180 天为 0.6%,270 天为 0.4%,365 天为 0.1%。手术与术后第 90 天(OR 3.67,95%CI,3.43-3.94,p<0.001)、第 180 天(OR 2.85,2.67-3.12,p<0.001)、第 270 天(OR 2.63,2.38-2.91,p<0.001)和第 365 天(OR 2.11,1.77-2.51,p<0.001)持续使用阿片类药物的可能性显著相关,而非手术对照组。在危险因素分析中,男性和单身与早期(90 和 180 天)持续使用阿片类药物有关,而丙型肝炎和术前苯二氮䓬类药物使用与晚期(270 和 365 天)持续使用阿片类药物有关。
许多手术或有创性操作与术后持续使用阿片类药物的风险增加有关。术后期间是动态的,风险因素随时间而变化。